Pfizer Q2 Earnings Forecast: Analysts Expect $0.57

Pfizer Inc. (PFE) is a leading biopharmaceutical company with a market cap of $145.7 billion, focusing on innovative medicines and vaccines. Analysts predict a Q2 2025 adjusted EPS of $0.57, down 5% from the previous year. For fiscal 2025, an adjusted EPS of $3.06 is expected, declining 1.6% from fiscal 2024.

Despite a drop in shares by 8.2% over the past year, Pfizer saw a 3.2% increase after reporting Q1 2025 adjusted EPS of $0.92, beating estimates. With a “Moderate Buy” rating from analysts, the stock is currently trading below the average price target of $27.71. Investors are optimistic about Pfizer’s pipeline and cost control measures.

Read more at Yahoo Finance: Pfizer Earnings Preview: What to Expect